NCT00223561

Methylphenidate and Driving Ability in Adult Patients With Attention-Deficit Hyperactivity Disorder

A Double Blind, Placebo-Controlled Crossover Study to Determine the Effects of Methylphenidate on Driving Ability in Adult Patients With Attention-Deficit Hyperactivity Disorder

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 18 (planned)
• Sponsor: Utrecht Institute for Pharmaceutical Sciences · Academic / Other
• Sex: All
• Age: 21 Years – 55 Years
• Healthy volunteers: Not accepted

Summary

The primary purpose of this study is to determine the effects of methylphenidate versus placebo on driving ability of adult ADHD patients.

Detailed description

This study was set-up to examine the controversial issue whether or not it is safe to drive a car or not when treated with methylphenidate. On-the-road driving tests during normal traffic are conducted to determine the effects of methylphenidate versus placebo on driving ability of adult ADHD patients.In addition, two laboratory tests are conducted to examine memory functioning and inhibitory control.

Conditions

• ADHD

Interventions

Type	Name	Description
DRUG	methylphenidate

Timeline

• Start date: 2003-02-01
• Completion: 2006-02-01
• First posted: 2005-09-22
• Last updated: 2006-03-01

Locations

1 site across 1 country: Netherlands